Johnson Johnson (JNJ)

Healthcare | Drug Manufacturers General
Latest reporting period: 2025-03-30

Latest Quarter

2025-03-30

Revenue

$21.9B

Net Income

$11.0B

Operating Margin

28.8%

Free Cash Flow

$19.7B

Debt / Assets

59.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Johnson Johnson (JNJ).
Income Statement (Quarterly) 2025-03-30 2024-12-29 2024-09-29 2024-09-28
Revenue 21,893,000,000 22,520,000,000 22,471,000,000 22,471,000,000
Cost of Revenue 7,357,000,000 7,128,000,000 6,963,000,000 6,783,000,000
Gross Profit 14,536,000,000 15,392,000,000 15,508,000,000 15,688,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 5,012,000,000 6,253,000,000 5,278,000,000 5,475,000,000
Operating Expenses 8,237,000,000 11,551,000,000 10,230,000,000 10,427,000,000
Operating Income 6,299,000,000 3,841,000,000 5,278,000,000 5,261,000,000
Interest Expense 204,000,000 137,000,000 193,000,000 0
Income Before Tax 13,631,000,000 3,887,000,000 3,338,000,000 3,338,000,000
Income Tax Expense 2,632,000,000 456,000,000 644,000,000 644,000,000
Net Income 10,999,000,000 3,431,000,000 2,694,000,000 2,694,000,000
Per Share
EPS 4.57 1.43 1.12 1.11
EPS Diluted 0.00 0.00 0.00 0.00